Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 1625 | 6488 | 36.7 | 75% |
Classes in level above (level 3) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 530 | 17046 | PRIMARY BILIARY CIRRHOSIS//AUTOIMMUNE HEPATITIS//PRIMARY SCLEROSING CHOLANGITIS |
Classes in level below (level 1) |
| ID, lev. below | Publications | Label for level below |
|---|---|---|
| 1748 | 2426 | PRIMARY BILIARY CIRRHOSIS//ANTIMITOCHONDRIAL ANTIBODIES//RHEUMATOL ALLERGY CLIN IMMUNOL |
| 2897 | 2042 | AUTOIMMUNE HEPATITIS//AUTOIMMUNE LIVER DISEASE//DE NOVO AUTOIMMUNE HEPATITIS |
| 5673 | 1523 | PRIMARY SCLEROSING CHOLANGITIS//SCLEROSING CHOLANGITIS//NORWEGIAN PSC |
| 20171 | 410 | RENAL TUBULAR DYSGENESIS//NEONATAL HEMOCHROMATOSIS//NEONATAL HAEMOCHROMATOSIS |
| 33672 | 87 | GIANT CELL HEPATITIS//SYNCYTIAL GIANT CELL HEPATITIS//POSTINFANTILE GIANT CELL HEPATITIS |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | PRIMARY BILIARY CIRRHOSIS | Author keyword | 846 | 61% | 14% | 895 |
| 2 | AUTOIMMUNE HEPATITIS | Author keyword | 735 | 65% | 11% | 691 |
| 3 | PRIMARY SCLEROSING CHOLANGITIS | Author keyword | 482 | 62% | 8% | 498 |
| 4 | ANTIMITOCHONDRIAL ANTIBODIES | Author keyword | 146 | 84% | 1% | 81 |
| 5 | RHEUMATOL ALLERGY CLIN IMMUNOL | Address | 109 | 33% | 4% | 276 |
| 6 | AUTOIMMUNE LIVER DISEASE | Author keyword | 83 | 69% | 1% | 71 |
| 7 | ANTIMITOCHONDRIAL ANTIBODY | Author keyword | 81 | 79% | 1% | 52 |
| 8 | AUTOIMMUNE CHOLANGITIS | Author keyword | 79 | 73% | 1% | 60 |
| 9 | RENAL TUBULAR DYSGENESIS | Author keyword | 58 | 86% | 0% | 30 |
| 10 | NEONATAL HEMOCHROMATOSIS | Author keyword | 40 | 72% | 0% | 31 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ANTIMITOCHONDRIAL ANTIBODIES | 415 | 85% | 3% | 216 |
| 2 | CHRONIC ACTIVE HEPATITIS | 353 | 34% | 13% | 841 |
| 3 | PRIMARY BILIARY CIRRHOSIS | 215 | 21% | 14% | 920 |
| 4 | SOLUBLE LIVER ANTIGEN | 192 | 91% | 1% | 80 |
| 5 | MITOCHONDRIAL AUTOANTIGENS | 177 | 98% | 1% | 46 |
| 6 | DIHYDROLIPOAMIDE ACETYLTRANSFERASE | 159 | 65% | 2% | 153 |
| 7 | ANTIMITOCHONDRIAL AUTOANTIBODIES | 153 | 98% | 1% | 41 |
| 8 | DOSE URSODEOXYCHOLIC ACID | 150 | 74% | 2% | 110 |
| 9 | AUTOIMMUNE HEPATITIS | 124 | 32% | 5% | 322 |
| 10 | KIDNEY MICROSOME ANTIBODY | 123 | 91% | 1% | 51 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Medical progress: Primary biliary cirrhosis | 2005 | 553 | 84 | 86% |
| Diagnosis and Management of Primary Sclerosing Cholangitis | 2010 | 206 | 175 | 77% |
| Medical progress: Autoimmune hepatitis | 2006 | 319 | 87 | 89% |
| Primary Biliary Cirrhosis | 2009 | 247 | 192 | 66% |
| Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review | 2012 | 48 | 51 | 84% |
| The diagnosis of primary biliary cirrhosis | 2014 | 11 | 56 | 98% |
| Extrahepatic Autoimmune Conditions Associated with Primary Biliary Cirrhosis | 2015 | 2 | 30 | 83% |
| Diagnosis and treatment of autoimmune hepatitis | 2002 | 291 | 187 | 87% |
| Medical progress - Primary biliary cirrhosis | 1996 | 393 | 126 | 78% |
| Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management | 2013 | 35 | 162 | 68% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | RHEUMATOL ALLERGY CLIN IMMUNOL | 109 | 33% | 4.3% | 276 |
| 2 | AUTOIMMUNE LIVER DIS | 30 | 60% | 0.5% | 32 |
| 3 | REFERENCE MALAD INFLAMMATOI VOIES BILIAIRE | 26 | 80% | 0.2% | 16 |
| 4 | LIVER STUDIES | 25 | 15% | 2.3% | 149 |
| 5 | NORWEGIAN PSC | 15 | 50% | 0.3% | 22 |
| 6 | NORWEGIAN PSC TRANSPLANTAT MED | 14 | 100% | 0.1% | 7 |
| 7 | SECT GASTROENTEROL TRANSPLANTAT MED | 12 | 86% | 0.1% | 6 |
| 8 | HEPATOBILIARY IMMUNOPATHOL UNIT | 9 | 55% | 0.2% | 11 |
| 9 | CHOLESTAT LIVER DIS STUDY GRP | 8 | 100% | 0.1% | 5 |
| 10 | CLIN AUTOIMMUNE LIVER DIS | 6 | 80% | 0.1% | 4 |
Related classes at same level (level 2) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000015450 | BILE ACIDS//FARNESOID X RECEPTOR//CEREBROTENDINOUS XANTHOMATOSIS |
| 2 | 0.0000010224 | LIVER TRANSPLANTATION//LIVING DONOR LIVER TRANSPLANTATION//HEPATIC ARTERY THROMBOSIS |
| 3 | 0.0000008718 | AUTOIMMUNE PANCREATITIS//INFLAMMATORY PSEUDOTUMOR//INFLAMMATORY MYOFIBROBLASTIC TUMOR |
| 4 | 0.0000007577 | THIOPURINE METHYLTRANSFERASE//6 MERCAPTOPURINE//THIOPURINE S METHYLTRANSFERASE |
| 5 | 0.0000007130 | HEPATIC STELLATE CELLS//HEPATIC STELLATE CELL//ACETAMINOPHEN |
| 6 | 0.0000006503 | CONGENITAL HEART BLOCK//NEONATAL LUPUS//NEONATAL LUPUS ERYTHEMATOSUS |
| 7 | 0.0000006059 | CHOLEDOCHOLITHIASIS//CHOLANGIOCARCINOMA//GALLSTONES |
| 8 | 0.0000005884 | NON ALCOHOLIC FATTY LIVER DISEASE//NON ALCOHOLIC STEATOHEPATITIS//TRANSIENT ELASTOGRAPHY |
| 9 | 0.0000005652 | ULCERATIVE COLITIS//CROHNS DISEASE//INFLAMMATORY BOWEL DISEASE |
| 10 | 0.0000005508 | POLYCYSTIC LIVER DISEASE//BILIARY CYSTADENOCARCINOMA//BILIARY CYSTADENOMA |